600332 白云山
已收盘 08-16 15:00:00
资讯
新帖
简况
白云山(00874.HK)分公司化学药品获药品补充申请批件
阿斯达克财经 · 08-16 16:51
白云山(00874.HK)分公司化学药品获药品补充申请批件
白云山(600332.SH):复方氨酚那敏颗粒获得药品补充申请批件
格隆汇 · 08-16 16:49
白云山(600332.SH):复方氨酚那敏颗粒获得药品补充申请批件
白云山控股子公司收FDA警告信 被指违反药品生产管理规范
中国经营网 · 08-15 14:49
白云山控股子公司收FDA警告信 被指违反药品生产管理规范
超级真菌概念盘中跳水,白云山跌0.76%
自选股智能写手 · 08-13
超级真菌概念盘中跳水,白云山跌0.76%
白云山8月12日获北向资金加仓146.69万股
自选股智能写手 · 08-13
白云山8月12日获北向资金加仓146.69万股
白云山(00874):注射用头孢唑肟钠已通过仿制药质量和疗效一致性评价
智通财经 · 08-12
白云山(00874):注射用头孢唑肟钠已通过仿制药质量和疗效一致性评价
白云山最新公告:注射用头孢唑肟钠通过仿制药一致性评价
证券之星 · 08-12
白云山最新公告:注射用头孢唑肟钠通过仿制药一致性评价
白云山(600332.SH):分公司药品通过仿制药一致性评价
格隆汇 · 08-12
白云山(600332.SH):分公司药品通过仿制药一致性评价
港股中医药股盘中强势,中国中药(00570.HK)涨近5%,神威药业(02877.HK)涨超3.5%,白云山(00874.
美港电讯 · 08-12
港股中医药股盘中强势,中国中药(00570.HK)涨近5%,神威药业(02877.HK)涨超3.5%,白云山(00874.
超级真菌概念盘中跳水,白云山跌1.44%
自选股智能写手 · 08-09
超级真菌概念盘中跳水,白云山跌1.44%
董事长突然离职,手握王老吉、金戈两大王牌的白云山进入关键时刻
子弹财经 · 08-09
董事长突然离职,手握王老吉、金戈两大王牌的白云山进入关键时刻
白云山(00874.HK):未获李楚源提供请辞详情
阿斯达克财经 · 08-08
白云山(00874.HK):未获李楚源提供请辞详情
【机构调研记录】金信基金调研白云山
证券之星 · 08-08
【机构调研记录】金信基金调研白云山
【机构调研记录】红土创新基金调研白云山
证券之星 · 08-08
【机构调研记录】红土创新基金调研白云山
【机构调研记录】易方达基金调研航天长峰、白云山
证券之星 · 08-08
【机构调研记录】易方达基金调研航天长峰、白云山
【机构调研记录】招商基金调研科博达、白云山
证券之星 · 08-08
【机构调研记录】招商基金调研科博达、白云山
【机构调研记录】广发基金调研科博达、白云山等3只个股(附名单)
证券之星 · 08-08
【机构调研记录】广发基金调研科博达、白云山等3只个股(附名单)
【机构调研记录】富国基金调研科博达、白云山等3只个股(附名单)
证券之星 · 08-08
【机构调研记录】富国基金调研科博达、白云山等3只个股(附名单)
【机构调研记录】华安基金调研白云山
证券之星 · 08-08
【机构调研记录】华安基金调研白云山
白云山: 公司通过积极参加国际展会、加快海外产品本地化改版、持续推进商标注册等,持续拓展海外市场
证券之星 · 08-07
白云山: 公司通过积极参加国际展会、加快海外产品本地化改版、持续推进商标注册等,持续拓展海外市场
暂无数据
公司概况
公司名称:
广州白云山医药集团股份有限公司
所属行业:
医药制造业
上市日期:
2001-02-06
主营业务:
广州白云山医药集团股份有限公司主营业务中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研究开发、制造与销售;西药、中药和医疗器械的批发、零售和进出口业务;大健康产品的研发、生产与销售;医疗服务、健康管理、养生养老等健康产业投资。公司产品主要包括中成药、中药饮片、化学制剂、化学原料药、医药流通。集团是全国最大的制药企业集团之一。本集团及合营企业拥有国家级研发机构7家,国家级企业技术中心1家,博士后工作站2家。
发行价格:
9.80
{"stockData":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":29.9,"timestamp":1723791600000,"preClose":29.76,"halted":0,"volume":4279682,"delay":0,"floatShares":1406000000,"shares":1626000000,"eps":2.5251,"marketStatus":"已收盘","marketStatusCode":5,"change":0.14,"latestTime":"08-16 15:00:00","open":29.67,"high":29.98,"low":29.57,"amount":128000000,"amplitude":0.0138,"askPrice":29.9,"askSize":52,"bidPrice":29.89,"bidSize":21,"shortable":0,"etf":0,"ttmEps":2.5251,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":29.76,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":32.74,"lowLimit":26.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1625790949,"pbRate":1.32,"roa":"--","roe":"5.45%","epsLYR":2.495,"committee":-0.591549,"marketValue":48611000000,"floatMarketCap":42036000000,"peRate":11.841115,"changeRate":0.0047,"turnoverRate":0.003,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-08-19。"},"requestUrl":"/m/hq/s/600332/tweets","defaultTab":"tweets","newsList":[{"id":"2459260408","title":"白云山(00874.HK)分公司化学药品获药品补充申请批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2459260408","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459260408?lang=zh_cn&edition=full","pubTime":"2024-08-16 16:51","pubTimestamp":1723798260,"startTime":"0","endTime":"0","summary":"白云山(00874.HK) 表示,控股子公司盈康药业近日收到国家药监局签发的《药品补充申请批准通知书》,复方氨酚那敏颗粒已按药品上市持有人主体变更申报途径进行申请,从而获得国家药监局批准变更相关内容。该药品上市许可持有人由芜湖绿叶制药变更为盈康药业。(ha/k)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-16 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200309160210932_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200309160210932_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1372344/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["600332","BK0096","BK1606","BK1515","BK0070","BK0239","BK0183","BK0196","BK0012","BK1521","BK1197","BK1191","BK0028","00874","BK0175","BK0188","BK0097"],"gpt_icon":0},{"id":"2459229899","title":"白云山(600332.SH):复方氨酚那敏颗粒获得药品补充申请批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2459229899","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459229899?lang=zh_cn&edition=full","pubTime":"2024-08-16 16:49","pubTimestamp":1723798187,"startTime":"0","endTime":"0","summary":"格隆汇8月16日丨白云山(600332.SH)公布,控股子公司广西白云山盈康药业有限公司收到国家药品监督管理局签发的《药品补充申请批准通知书》,复方氨酚那敏颗粒已按药品上市持有人主体变更申报途径进行申请,从而获得国家药监局批准变更相关内容。复方氨酚那敏颗粒用于缓解普通感冒及流行性感冒引起的发热、头痛、鼻塞、打喷嚏等症状。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816164947ab5e0471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816164947ab5e0471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0097","BK0028","BK0239","BK0096","BK0070","BK0175","BK0183","600332","BK0188","BK0196","BK0012"],"gpt_icon":0},{"id":"2459413958","title":"白云山控股子公司收FDA警告信 被指违反药品生产管理规范","url":"https://stock-news.laohu8.com/highlight/detail?id=2459413958","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459413958?lang=zh_cn&edition=full","pubTime":"2024-08-15 14:49","pubTimestamp":1723704595,"startTime":"0","endTime":"0","summary":"近日,美国食品药品监督管理局官网披露一封对广州白云山敬修堂药业股份有限公司的警告信,其中指出,FDA在2023年12月4—8日对敬修堂一处药品生产场地进行现场检查,发现其制剂产品存在违反CGMP的显著缺陷。截至8月14日,白云山仍未对子公司收到FDA警告信一事作公开披露。白云山方面则称采访函收悉,但截至发稿未予以回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151509219f2cded4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151509219f2cded4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","600332","BK0028","BK0183","BK0096","BK0012","BK0097","BK0188","BK0239","BK0175","BK0070"],"gpt_icon":0},{"id":"2459991371","title":"超级真菌概念盘中跳水,白云山跌0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459991371","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459991371?lang=zh_cn&edition=full","pubTime":"2024-08-13 09:42","pubTimestamp":1723513344,"startTime":"0","endTime":"0","summary":"08月13日,超级真菌概念盘中跳水,截至09点42分,超级真菌概念整体指数下跌1.26%,报674.080点。从个股上来看,该概念的成分股中,白云山跌0.76%,重药控股、博瑞医药、鲁抗医药跌幅居前。从资金上来看,截止发稿,超级真菌概念主力净流入为-2486.76万,其中东北制药受到资金热捧,主力净流入7343.40万;拉长时间线来看,该板块近20日主力资金净流入-15.59亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081309422496825da6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081309422496825da6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","BK0028","BK0096","BK0196","BK0239","BK0012","BK0097","BK0070","600332","00874","BK0183","BK0188"],"gpt_icon":0},{"id":"2459999695","title":"白云山8月12日获北向资金加仓146.69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459999695","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459999695?lang=zh_cn&edition=full","pubTime":"2024-08-13 09:30","pubTimestamp":1723512610,"startTime":"0","endTime":"0","summary":"8月12日, 北向资金增持白云山146.69万股。截止当日收盘,沪股通共持有白云山3871.24万股,占流通股2.75%。沪股通增持金额前五个股分别为太极集团、长江电力、宇通客车、伊利股份、中国船舶。白云山近5个交易日上涨2.17%,沪股通累计增持142.87万股;近20个交易日上涨1.72%,沪股通累计增持261.47万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130930479593c581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130930479593c581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600332","00874","BK1191","BK1515","BK1606","BK1521","BK1197"],"gpt_icon":0},{"id":"2458670585","title":"白云山(00874):注射用头孢唑肟钠已通过仿制药质量和疗效一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2458670585","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458670585?lang=zh_cn&edition=full","pubTime":"2024-08-12 18:09","pubTimestamp":1723457369,"startTime":"0","endTime":"0","summary":"智通财经APP讯,白云山(00874)发布公告,近日,广州白云山医药集团股份有限公司(以下简称“本公司”)分公司广州白云山医药集团股份有限公司白云山制药总厂(以下简称“白云山制药总厂”)收到国家药品监督管理局核准签发的《药品补充申请批准通知书》,注射用头孢唑肟钠已通过仿制药质量和疗效一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK1515","BK0097","BK0183","BK1197","BK1521","BK0028","BK0188","BK1606","BK0175","BK0196","600332","00874","BK0239","BK0096","BK1191","BK0070"],"gpt_icon":0},{"id":"2458672072","title":"白云山最新公告:注射用头孢唑肟钠通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2458672072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458672072?lang=zh_cn&edition=full","pubTime":"2024-08-12 17:51","pubTimestamp":1723456285,"startTime":"0","endTime":"0","summary":"白云山公告,公司分公司白云山制药总厂的注射用头孢唑肟钠通过仿制药质量和疗效一致性评价。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200024177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0175","BK0196","600332","BK0239","BK1197","BK1521","BK0188","BK0097","BK0096","00874","BK0183","BK0012","BK1191","BK1606","BK0028","BK0070"],"gpt_icon":0},{"id":"2458767244","title":"白云山(600332.SH):分公司药品通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2458767244","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458767244?lang=zh_cn&edition=full","pubTime":"2024-08-12 17:42","pubTimestamp":1723455724,"startTime":"0","endTime":"0","summary":"格隆汇8月12日丨白云山(600332.SH)公布,公司分公司广州白云山医药集团股份有限公司白云山制药总厂(称“白云山制药总厂”)收到国家药品监督管理局核准签发的《药品补充申请批准通知书》,注射用头孢唑肟钠已通过仿制药质量和疗效一致性评价。头孢唑肟钠属于第三代头孢菌素,主要用于治疗敏感菌所致的下呼吸道感染、尿路感染、腹腔感染、盆腔感染、败血症、皮肤软组织感染、骨和关节感染、肺炎链球菌或流感嗜血杆菌所致脑膜炎和单纯性淋病等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812174204a1d42d25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812174204a1d42d25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0097","BK0196","600332","BK0070","BK0188","BK0028","BK0183","BK0239","BK0175","BK0096"],"gpt_icon":0},{"id":"2458644057","title":"港股中医药股盘中强势,中国中药(00570.HK)涨近5%,神威药业(02877.HK)涨超3.5%,白云山(00874.","url":"https://stock-news.laohu8.com/highlight/detail?id=2458644057","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458644057?lang=zh_cn&edition=full","pubTime":"2024-08-12 11:10","pubTimestamp":1723432220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["HSCEI","07226","BK0096","BK0239","BK0188","BK0196","00570","BK0097","BK0175","YANG","BK1583","600332","00874","BK0012","BK1521","01666","HSTECH","BK0183","BK1191","BK1606","BK0028","BK1515","BK0070","02877","BK1197"],"gpt_icon":0},{"id":"2458535877","title":"超级真菌概念盘中跳水,白云山跌1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458535877","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458535877?lang=zh_cn&edition=full","pubTime":"2024-08-09 14:10","pubTimestamp":1723183839,"startTime":"0","endTime":"0","summary":"08月09日,超级真菌概念盘中跳水,截至14点10分,超级真菌概念整体指数下跌2.04%,报670.920点。从个股上来看,该概念的成分股中,白云山跌1.44%,国药现代、华神科技、海正药业跌幅居前。从资金上来看,截止发稿,超级真菌概念主力净流入为-1.16亿,其中东北制药受到资金热捧,主力净流入1.60亿;拉长时间线来看,该板块近20日主力资金净流入-12.92亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080914103996825675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080914103996825675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","600332","BK0028","00874","BK0183","BK0096","BK0012","BK0097","BK0188","BK0239","BK0175","BK0070"],"gpt_icon":0},{"id":"2458588797","title":"董事长突然离职,手握王老吉、金戈两大王牌的白云山进入关键时刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458588797","media":"子弹财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458588797?lang=zh_cn&edition=full","pubTime":"2024-08-09 10:47","pubTimestamp":1723171620,"startTime":"0","endTime":"0","summary":"7月22日晚,白云山公告称收到董事长李楚源的书面辞职报告。坊间称,李楚源已被有关部门带走调查。在李楚源任董事长的十多年间,白云山的营收从2013年的176亿元增长至2023年的755亿元,王老吉、金戈成为白云山的拳头产品,为公司带来显著的业绩增长。李楚源此次离职,是否与早年的举报事件以及子公司违规事件有关,现不得而知,但随着核心人物突然离职,或许意味着白云山将面临深层次的变革。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408091047429f1c2eef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408091047429f1c2eef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0028","BK0239","BK0096","BK0070","BK0188","BK0183","BK0175","600332","BK0097","BK0196","00874"],"gpt_icon":0},{"id":"2457236453","title":"白云山(00874.HK):未获李楚源提供请辞详情","url":"https://stock-news.laohu8.com/highlight/detail?id=2457236453","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457236453?lang=zh_cn&edition=full","pubTime":"2024-08-08 17:23","pubTimestamp":1723108980,"startTime":"0","endTime":"0","summary":"白云山(00874.HK) 发补充公告指,在7月22日收到李楚源递交的书面辞职报告,以“个人原因”辞去公司董事会董事长、执行董事及董事会战略发展与投资委员会主任的职务,而李楚源未有就“个人原因”进一步作出阐释,仅确认与董事会并无意见分歧。公司指,截至今日仍未获李楚源提供的请辞详情。(vc/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-08 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190128164618458_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190128164618458_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1370099/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0196","BK0175","BK0012","BK0183","BK1191","600332","BK1521","BK1515","BK0028","BK1606","BK0096","BK0239","00874","BK1197","BK0188","BK0070","BK0097"],"gpt_icon":0},{"id":"2457800376","title":"【机构调研记录】金信基金调研白云山","url":"https://stock-news.laohu8.com/highlight/detail?id=2457800376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457800376?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:01","pubTimestamp":1723075300,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为金信智能中国2025混合A,最新单位净值为1.7,近一年增长13.51%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800012155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","BK0028","BK1521","BK0012","BK1197","BK0175","BK0239","BK0196","BK1191","600332","BK0070","BK0096","BK1515","BK0097","BK0188","00874","BK0183"],"gpt_icon":0},{"id":"2457800578","title":"【机构调研记录】红土创新基金调研白云山","url":"https://stock-news.laohu8.com/highlight/detail?id=2457800578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457800578?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:01","pubTimestamp":1723075298,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为红土创新增强收益债券A,最新单位净值为1.42,近一年增长7.3%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800012150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","BK0028","BK1521","BK0012","BK1197","BK0175","BK0239","BK0196","BK1191","600332","BK0070","BK0096","BK1515","BK0097","BK0188","00874","BK0183"],"gpt_icon":0},{"id":"2457800526","title":"【机构调研记录】易方达基金调研航天长峰、白云山","url":"https://stock-news.laohu8.com/highlight/detail?id=2457800526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457800526?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:01","pubTimestamp":1723075292,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月7日披露的机构调研信息,易方达基金近期对2家上市公司进行了调研,相关名单如下:1)航天长峰 个股亮点:公司军工电子业务主要为军工电源产业;子公司长峰科技以安保科技系统产业项目为主营业务;公司成功打造了全国首个开放式高速公路车路协同测试验证平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800012141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600855","BK0097","BK1515","BK0012","BK0028","BK0188","BK1521","BK0239","BK0196","BK0041","BK0037","BK0183","BK0010","BK1191","BK1606","BK0096","BK1197","BK0058","BK0070","00874","BK0175","600332","BK0251"],"gpt_icon":0},{"id":"2457800551","title":"【机构调研记录】招商基金调研科博达、白云山","url":"https://stock-news.laohu8.com/highlight/detail?id=2457800551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457800551?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:01","pubTimestamp":1723075291,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月7日披露的机构调研信息,招商基金近期对2家上市公司进行了调研,相关名单如下:1)科博达 个股亮点:公司参股公司上海科博达智能科技有限公司主要从事智驾领域相关技术解决方案服务及提供智驾相关硬件产品生产。旗下最近一年表现最佳的公募基金产品为招商招轩纯债A,最新单位净值为1.51,近一年增长37.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800012137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1197","BK0028","BK0183","600332","BK0264","BK1606","00874","603786","BK0096","BK0070","BK1515","BK0097","BK0188","BK1521","BK0012","BK0239","BK0175","BK1191","BK0196"],"gpt_icon":0},{"id":"2457800545","title":"【机构调研记录】广发基金调研科博达、白云山等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2457800545","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457800545?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:01","pubTimestamp":1723075288,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月7日披露的机构调研信息,广发基金近期对3家上市公司进行了调研,相关名单如下:1)科博达 个股亮点:公司参股公司上海科博达智能科技有限公司主要从事智驾领域相关技术解决方案服务及提供智驾相关硬件产品生产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800012131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","600332","BK1606","BK0239","BK0070","BK1521","BK1515","BK0196","BK0264","BK0175","BK0188","BK1197","BK0012","BK0028","BK0096","603786","BK1191","00874","BK0183"],"gpt_icon":0},{"id":"2457280051","title":"【机构调研记录】富国基金调研科博达、白云山等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2457280051","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457280051?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:01","pubTimestamp":1723075286,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月7日披露的机构调研信息,富国基金近期对3家上市公司进行了调研,相关名单如下:1)科博达 个股亮点:公司参股公司上海科博达智能科技有限公司主要从事智驾领域相关技术解决方案服务及提供智驾相关硬件产品生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800012126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK1521","BK0028","BK0239","BK0196","600332","BK0096","BK0097","BK0175","BK0264","BK0070","BK1197","603786","BK1191","BK0188","BK1515","BK1606","BK0183","00874"],"gpt_icon":0},{"id":"2457480054","title":"【机构调研记录】华安基金调研白云山","url":"https://stock-news.laohu8.com/highlight/detail?id=2457480054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457480054?lang=zh_cn&edition=full","pubTime":"2024-08-08 08:01","pubTimestamp":1723075274,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为华安黄金易ETF,最新单位净值为5.35,近一年增长21.32%。旗下最新募集公募基金产品为华安景气回报混合发起式A,类型为混合型-偏股,集中认购期2024年6月14日至2024年9月13日。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800012107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","BK0070","BK0196","BK0239","600332","BK0097","BK0012","BK1197","00874","BK0175","BK0183","BK0028","BK1521","BK1515","BK0188","BK1191","BK0096"],"gpt_icon":0},{"id":"2457818038","title":"白云山:\n公司通过积极参加国际展会、加快海外产品本地化改版、持续推进商标注册等,持续拓展海外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2457818038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457818038?lang=zh_cn&edition=full","pubTime":"2024-08-07 18:01","pubTimestamp":1723024870,"startTime":"0","endTime":"0","summary":"公司通过积极参加国际展会、加快海外产品本地化改版、持续推进商标注册等,持续拓展海外市场。根据公司定期报告公布信息,目前未单独披露该产品海外销售数据。公司王老吉凉茶在全国各地主要地区均有销售,同时公司积极布局海外市场。公司严格按照两地上市规则要求进行信息披露,相关信息以公司公开披露情况为准。目前已有多家企业获得该药品批文,公司将继续加大力度推进该产品的销售工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700037729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0175","BK0012","BK0183","BK1191","600332","BK1521","BK1515","BK0028","BK1606","BK0096","BK0239","00874","BK1197","BK0188","BK0070","BK0097"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2001-02-06","address":"广东省广州市荔湾区沙面北街45号","stockEarnings":[{"period":"1week","weight":0.0184},{"period":"1month","weight":-0.0086},{"period":"3month","weight":-0.0604},{"period":"6month","weight":0.054},{"period":"1year","weight":-0.0282},{"period":"ytd","weight":0.0717}],"companyName":"广州白云山医药集团股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"162579万元","compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0282},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.0047},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.0321}],"survey":" 广州白云山医药集团股份有限公司主营业务中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研究开发、制造与销售;西药、中药和医疗器械的批发、零售和进出口业务;大健康产品的研发、生产与销售;医疗服务、健康管理、养生养老等健康产业投资。公司产品主要包括中成药、中药饮片、化学制剂、化学原料药、医药流通。集团是全国最大的制药企业集团之一。本集团及合营企业拥有国家级研发机构7家,国家级企业技术中心1家,博士后工作站2家。","serverTime":1723833735749,"listedPrice":9.8,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(600332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,600332,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(600332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}